Bone health study after kidney transplant
Part of Bones, joints & muscles, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at bone and mineral disorders in people on dialysis, after a kidney transplant, or with bone thinning. It aims to understand how these conditions affect bone health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 70 years old.
- If you are on dialysis, you must have been doing it for at least 12 months.
- If you have had a kidney transplant, it must have been at least 12 months ago and the kidney must be working well.
- If you have bone thinning, you must be a man or a woman after menopause, between 50 and 70 years old.
- You cannot be taking certain bone medications (other than calcium or vitamin D) or have recent cancer or serious fractures.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people getting a liver transplant. It looks at bone health and mineral levels in the body to better understand how they change after transplant.
This study follows people who recently received a kidney transplant to see how bone strength and blood-vessel calcifications change over time. It may help doctors better understand what to monitor after transplant and how best to protect bone and heart health.
This trial looks at a personalized approach to diagnosing and treating bone problems caused by long-term kidney disease. It may help by matching treatment plans to the type of bone turnover found in your tests or biopsy.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study checks how kidney disease affects bone health by measuring hormones like PTH and related blood markers. It may help doctors better diagnose bone problems that can occur with poor kidney function.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
Hear when a new Hemodyalysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.